"China Olympics" completes A round A financing

IT Orange News on September 16th, Innovation Pharmaceutical R & D Corporation of China Olympic Biomedical Technology (Guangdong) Co., Ltd. completed the A round of financing. Investors include Huaying Capital, a fund under the Torch Development Zone of Zhongshan City, and a subordinate of Sanno Bio, a listed company in science and technology. Investment company St. Ronglangko, as well as old shareholders.

According to public information, China Olympic Biomedical Technology (Guangdong) Co., Ltd. is an innovative pharmaceutical research and development company founded by foreign Chinese scientists. It was registered and established in Guangzhou in November 2018 and moved to Zhongshan in June 2022. At present, the company's employees include 4 foreign doctors, 3 foreign Chinese doctors, 2 doctors, and 12 masters. Research areas: other diseases caused by malignant tumors such as skin cancer, cervical cancer, liver cancer and other diseases caused by human papilloma (HPV) virus. Company positioning: It provides a conversion platform for the research results obtained by the company's original team in the past 20 years.

Cervical cancer is the fourth largest malignant tumor in the world, and it is also the largest gynecological malignant tumor in my country. Studies have shown that high -risk HPV continuous infections can cause cervical cancer, and more than 90%of cervical cancer is related to high -risk HPV infection. HPV is the abbreviation of Human Papillomavirus (HPV). Human papilloma virus belongs to the genus A of the nipple virus A of the Department of Milk Virus, which is a spherical DNA virus, which can cause squamous epithelium proliferation of human skin and mucous membranes. It manifests symptoms such as ordinary warts, genital warts (condyloma acuminatum) or cervical cancer. With the incidence of condyloma acuminatum in sexually transmitted diseases rising rapidly and the increase in cervical cancer, anal cancer, etc., human papilloma virus (HPV) infection has increasingly attracted people's attention.

Smart buds enterprise science and innovation assessment platform shows that a total of one public application for Chinese and Olympic creatures is a patent for invention, which is mainly related to the fields of polypeptide compositions and leather agents.

- END -